Meet Dr. Dana Chase, our newest member of the Division of Gynecologic Oncology
UCLA Obstetrics and Gynecology is pleased to announce the recruitment of Dana Chase, MD, as an associate professor in the Division of Gynecologic Oncology. Dr. Chase comes to UCLA most previously from the Department of Obstetrics and Gynecology at the Creighton University Phoenix Campus and University of Arizona in Phoenix and brings with her a wealth of experience in gynecologic oncology symptom management, surgery and novel therapeutics, as well as quality of life research related to gynecologic cancers.
In concert with her clinical practice as a gynecologic oncologist and surgeon, Dr. Chase will broaden the clinical research efforts within the division to include studies that focus on underrepresented patient populations in gynecologic cancers such as reducing toxicity in treatment for seasoned women (70 years+) to improve outcomes and quality of life. She will continue to work on bringing more clinical trials to underrepresented populations which helps to apply results to real-world patients who may not have been traditionally included in these studies.
Survivorship and quality of life concerns are at the heart of Dr. Chase’s work, and thus her collaboration with the Gynecologic Oncology Survivorship Program team to expand the program. This expansion will include a focus on cognitive decline, fatigue, and sleep disturbance as well as surveillance after treatment, including interventions to improve quality of life during and after treatment. She is interested in related clinical studies looking at the balance of treatment toxicity to quality-of-life outcomes. “We want our cancer patients to not just live longer, but to recover from the trauma of cancer diagnosis and treatment,” says Dr. Chase.
With ties to Southern California having grown up in Los Angeles and trained at UC Irvine for both her residency and fellowship, Dr. Chase is delighted to be at UCLA. She says, “I am looking forward to joining the impressive group of faculty here at UCLA where the focus is not only on excellent patient care but also on advancing the science of treating gynecologic cancers from all angles including new cancer treatments as well as novel approaches to managing side effects, improving access to trials, and increasing early diagnosis and/or prevention.”
Dr. Chase is a member of the GOG Partners Investigator Council and serves on NRG Oncology’s Cancer Prevention & Control Committee as well as the Patient Centered Outcomes Research Committee.